Ferritin‐Based Nanomotors for Deep Glioblastoma Penetration and Enhanced Drug Delivery
Macromolecular Bioscience · 2026
DOI: 10.1002/mabi.70267 ↗Kurz gefasst
Fachartikel in der Zeitschrift Macromolecular Bioscience, 2026. Verfasst von Jun Ma und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Texas A&M University, College Station, Texas, United States. Hauptthemen laut MEDLINE: Glioblastoma, Doxorubicin, Apoferritins, Drug Delivery Systems. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Texas A&M President.
Abstract (Originalsprache)
Poor penetration into tumor tissue remains a major barrier to effective nanomedicine delivery, particularly in glioblastoma multiforme (GBM). Here, nanoparticle transport was computationally studied to rationally design an ultrasmall chemotactic nanomotor that improves penetration into dense tumor tissue. The nanomotor comprises a targeting human heavy‐chain ferritin (HFn) nanocage and a catalytic cerium oxide (CeO 2 ) component. Leveraging transferrin receptor‑1 overexpression on brain microvascular endothelial cells and GBM cells, HFn enables transport across an in vitro blood–brain barrier (BBB) model and accumulation in GBM spheroids. The CeO 2 domain catalyzes hydrogen peroxide decomposition in the tumor‑mimicking microenvironment, generating oxygen and imparting directional propulsion along H 2 O 2 gradients. In chemotaxis assays, the nanomotors actively migrated toward localized H 2 O 2 sources and GBM cells embedded in Matrigel. In large U87 spheroids (>400 µm), HFn@CeO 2 nanomotors penetrated deeply and distributed throughout the spheroid core, whereas non‑propelled HFn nanocarriers remained confined mainly to the periphery. Doxorubicin‑loaded nanomotors (HFn@CeO 2– DOX) achieved substantially enhanced intratumoral DOX distribution and reduced IC 50 (0.33 µM) compared with HFn–DOX (1.13 µM) and free DOX (1.75 µM) in GBM spheroids. These results provide a promising basis for future in vivo evaluation in brain tumor therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, Texas A&M University, College Station, Texas, United States.
- Department of Materials Science and Engineering, Texas A&M University, College Station, Texas, United States.
- Department of Radiation Oncology, Mass General Brigham Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States.
- Department of Mechanical Engineering, Texas A&M University, College Station, Texas, United States.
- Department of Industrial Systems and Engineering, Texas A&M University, College Station, Texas, United States.
ORCID-Profile: Ruochen Liu, Ibrahim Chamseddine, Jingjing Qiu, Shiren Wang
Förderung
- Texas A&M President
Zitieren
APA
Ma, J., Liu, R., Chamseddine, I., Qiu, J., & Wang, S. (2026). Ferritin‐Based Nanomotors for Deep Glioblastoma Penetration and Enhanced Drug Delivery. Macromolecular Bioscience. https://doi.org/10.1002/mabi.70267
Vancouver
Ma J, Liu R, Chamseddine I, Qiu J, Wang S. Ferritin‐Based Nanomotors for Deep Glioblastoma Penetration and Enhanced Drug Delivery. Macromolecular Bioscience. 2026. doi:10.1002/mabi.70267
BibTeX
@article{Ma2026,
author = {Ma, Jun and Liu, Ruochen and Chamseddine, Ibrahim and Qiu, Jingjing and Wang, Shiren},
title = {Ferritin‐Based Nanomotors for Deep Glioblastoma Penetration and Enhanced Drug Delivery},
journal = {Macromolecular Bioscience},
year = {2026},
doi = {10.1002/mabi.70267}
}
EUVIMED